David Vaux

Prof. David Vaux

orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
WVWinnok H De Vos
Winnok H De Vos
FHFrederik Houben
Frederik Houben
MKMiriam Kamps
Miriam Kamps
AMAshraf Malhas
Ashraf Malhas
FVFons Verheyen
Fons Verheyen
Jos LV BroersJos LV Broers
Jos LV Broers
The nuclear lamina provides structural support to the nucleus and has a central role in nuclear organization and gene regulation. Defects in its constituents, the lamins, lead to a class of genetic diseases collectively referred to as laminopathies. Using live cell imaging, we observed the occurrence of intermittent, non-lethal ruptures of the nuclear envelope in dermal fibroblast cultures of patients with different mutations of lamin A/C. These ruptures, which were absent in normal fibroblasts, could be mimicked by selective knockdown as well as knockout of LMNA and were accompanied by the loss of cellular compartmentalization. This was demonstrated by the influx of cytoplasmic transcription factor RelA and regulatory protein Cyclin B1 into the nucleus, and efflux of nuclear transcription factor OCT1 and nuclear structures containing the promyelocytic leukemia (PML) tumour suppressor protein to the cytoplasm. While recovery of enhanced yellow fluorescent protein-tagged nuclear localization signal in the nucleus demonstrated restoration of nuclear membrane integrity, part of the mobile PML structures became permanently translocated to the cytoplasm. These satellite PML structures were devoid of the typical PML body components, such as DAXX, SP100 or SUMO1. Our data suggest that nuclear rupture and loss of compartmentalization may add to cellular dysfunction and disease development in various laminopathies.

1 June 2011 in Trends in Cell Biology
Verified
Journal Article
Closed access
AMAshraf Malhas
Ashraf Malhas
CGChris Goulbourne
Chris Goulbourne
DVDavid Vaux
David Vaux

9 February 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
DHDuncan Howie
Duncan Howie
SCStephen Paul Cobbold
Stephen Paul Cobbold
EAElizabeth Adams
Elizabeth Adams
ABAnnemieke Ten Bokum
Annemieke Ten Bokum
ANAndra Stefania Necula
Andra Stefania Necula
HWHerman Waldmann
Herman Waldmann
Tregs can adopt a catabolic metabolic program with increased capacity for fatty acid oxidation–fueled oxidative phosphorylation (OXPHOS). It is unclear why this form of metabolism is favored in Tregs and, more specifically, whether this program represents an adaptation to the environment and developmental cues or is “hardwired” by Foxp3. Here we show, using metabolic analysis and an unbiased mass spectroscopy–based proteomics approach, that Foxp3 is both necessary and sufficient to program Treg-increased respiratory capacity and Tregs’ increased ability to utilize fatty acids to fuel oxidative phosphorylation. Foxp3 drives upregulation of components of all the electron transport complexes, increasing their activity and ATP generation by oxidative phosphorylation. Increased fatty acid β-oxidation also results in selective protection of Foxp3 + cells from fatty acid–induced cell death. This observation may provide novel targets for modulating Treg function or selection therapeutically.


23 July 2001 in Journal of Cell Biology
Verified
Journal Article
Open access
MHMichael Hollinshead
Michael Hollinshead
GRGaener Rodger
Gaener Rodger
HEHenriette Van Eijl
Henriette Van Eijl
MLMansun Law
Mansun Law
RHRuth Hollinshead
Ruth Hollinshead
GSGeoffrey L. Smith
Geoffrey L. Smith
Vaccinia virus (VV) egress has been studied using confocal, video, and electron microscopy. Previously, intracellular-enveloped virus (IEV) particles were proposed to induce the polymerization of actin tails, which propel IEV particles to the cell surface. However, data presented support an alternative model in which microtubules transport virions to the cell surface and actin tails form beneath cell-associated enveloped virus (CEV) particles at the cell surface. Thus, VV is unique in using both microtubules and actin filaments for egress. The following data support this proposal. (a) Microscopy detected actin tails at the surface but not the center of cells. (b) VV mutants lacking the A33R, A34R, or A36R proteins are unable to induce actin tail formation but produce CEV and extracellular-enveloped virus. (c) CEV formation is inhibited by nocodazole but not cytochalasin D or 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine (PP1). (d) IEV particles tagged with the enhanced green fluorescent protein fused to the VV B5R protein moved inside cells at 60 μm/min. This movement was stop-start, was along defined pathways, and was inhibited reversibly by nocodazole. This velocity was 20-fold greater than VV movement on actin tails and consonant with the rate of movement of organelles along microtubules.

1 April 2010 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
NMNicola Martin
Nicola Martin
SWSonja Welsch
Sonja Welsch
CJClare Jolly
Clare Jolly
JBJohn A. G. Briggs
John A. G. Briggs
DVDavid Vaux
David Vaux
QSQuentin Sattentau
Quentin Sattentau
Human immunodeficiency virus type 1 (HIV-1) can disseminate between CD4 + T cells via diffusion-limited cell-free viral spread or by directed cell-cell transfer using virally induced structures termed virological synapses. Although T-cell virological synapses have been well characterized, it is unclear whether this mode of viral spread is susceptible to inhibition by neutralizing antibodies and entry inhibitors. We show here that both cell-cell and cell-free viral spread are equivalently sensitive to entry inhibition. Fluorescence imaging analysis measuring virological synapse lifetimes and inhibitor time-of-addition studies implied that inhibitors can access preformed virological synapses and interfere with HIV-1 cell-cell infection. This concept was supported by electron tomography that revealed the T-cell virological synapse to be a relatively permeable structure. Virological synapse-mediated HIV-1 spread is thus efficient but is not an immune or entry inhibitor evasion mechanism, a result that is encouraging for vaccine and drug design.